autoimmun disease
Conditions
Interventions
autoimmune disease group:NA
healthy control group:NA
Sponsors
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: From January to June 2024, the clinical residual serum of patients with autoantibody detection in Renji Hospital, and meet any of the following requirements: a. Anti-nuclear antibody indirect immunofluorescence detection is one of the 30 ANA patterns defined by ICAP, with a single karyotype and a titer >1:320; b. Clinically diagnosed as autoimmune disease, antinuclear antibody indirect immunofluorescence titer > 1:320, and common ANA autoantibodies results are negative; c. Clinically diagnosed systemic lupus erythematosus, Sjogren's syndrome, systemic sclerosis, mixed connective tissue disease, immune myopathy, autoimmune liver disease, and undifferentiated connective tissue disease.
Exclusion criteria
Exclusion criteria: a. The sample information is confusing and vague; b. Sample volume less than 0.5mL c. Severe jaundice, severe lipemia, severe hemolysis, severe pollution
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| antinuclear antibody; | — |
Countries
China
Contacts
Public ContactBing Zheng
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Outcome results
None listed